Sham-LP

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)NCT06617429RAREPhase 3Terminated2026-07-10Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.